MeiraGTx Holdings plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGTX research report →
About the company
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses. Its development efforts span a broad spectrum of conditions, encompassing ocular diseases like inherited forms of blindness, as well as xerostomia (dry mouth) that often follows radiation treatment for head and neck cancers. The company also targets various degenerative and neurodegenerative disorders, notably amyotrophic lateral sclerosis (ALS) and Parkinson's disease.
- CEO
- Alexandria Forbes
- IPO
- 2018
- Employees
- 375
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $1.29B
- P/E
- -9.41
- P/S
- 16.16
- P/B
- -19.47
- EV/EBITDA
- -13.64
- Div Yield
- 0.00%
- Gross Margin
- 91.64%
- Op Margin
- -131.89%
- Net Margin
- -151.12%
- ROE
- 474.91%
- ROIC
- -109.97%
- Revenue
- $81.39M · 144.57%
- Net Income
- $-114,201,000 · 22.73%
- EPS
- $-1.42 · 33.02%
- Op Income
- $-105,968,000
- FCF YoY
- 54.15%
- 52W High
- $13.94
- 52W Low
- $6.62
- 50D MA
- $10.11
- 200D MA
- $8.63
- Beta
- 1.21
- Avg Volume
- 989.32K
Get TickerSpark's AI analysis on MGTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 26 | Zeldin Robert K | other | 100,000 |
| Jun 25, 26 | Wollin Robert J | other | 100,000 |
| Jun 25, 26 | Naylor Stuart | other | 70,000 |
| Jun 25, 26 | Giroux Richard | other | 980,000 |
| Jun 25, 26 | Forbes Alexandria | other | 980,000 |
| Jun 11, 26 | Yu Debra | other | 60,000 |
| Jun 11, 26 | SHENK THOMAS E | other | 69,662 |
| Jun 11, 26 | Seligman Nicole | other | 60,000 |
| Jun 11, 26 | Mendoza Neil | other | 66,641 |
| Jun 11, 26 | Hukkelhoven Ellen | other | 60,000 |
Our MGTX coverage
Recent articles, reports, and earnings notes.
No research on MGTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MGTX report →Similar companies
Peers in the same neighborhood.